Drummond MF, Barbieri M, Wong JB. Analytic choices in economic models of treatments for rheumatoid arthritis. What makes a difference?Med Decis Making. 2005;25:520–533.
2.
Hawkins N, Sculpher M, Epstein D. Cost-effectiveness analysis of treatments for chronic disease—Using R to incorporate time-dependency of treatment response. Med Decis Making. 2005;25: 511–519.
3.
Hawkins N, Epstein D, Drummond M, et al. Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model. Med Decis Making. 2005;25:493–510.
4.
Berger M, Teutsch S. Commentary: cost effectiveness analysis: from science to application. Med Care. 2005;43:II-II-49–53.
5.
Daniels N, Sabin J. Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philos Public Affairs. 1997;26:303–350.
6.
Teutsch SM, Berger ML, Weinstein M. Comparative effectiveness: asking the right question, choosing the right method. Health Affairs. 2005;24:128–132.
7.
Helfand M, Morton S, Guallar E, Mulrow C, eds. Challenges of summarizing better information for better health: the evidence-based practice center experience. Ann Intern Med. 2005;142(12, part 2):1033–1126.
8.
Lomas J, Culyer T, McCutcheon C, McAuley L, Law S. Conceptualizing and Combining Evidence for Health System Guidance. Ottawa: Canadian Health Services Research Foundation; 2005.
